 |
 | Diagnosis and Prognosis of Pancreatitis |
| |  | Analysis of Amylase and Lipase Results in the Diagnosis of Pancreatitis |
| | | Algorithm for the Diagnosis of Acute Pancreatitis |
| | | Lipase-to-Amylase Ratio |
| | | RansonÕs Prognostic Factors in Acute Pancreatitis |
| | | Glasgow Prognostic Criteria in Acute Pancreatitis (Imrie Criteria) |
| | | CT Severity Index (Balthazar Score) in Acute Pancreatitis |
| | | Prognostic Factors for Acute Pancreatitis of Jacobs et al |
| | | Scoring System of Stimac et al to Distinguish Biliary from Alcoholic Pancreatitis |
| | | Clinical Criteria in Acute Pancreatitis of Bank et al. |
| | | Simplified Prognostic Criteria of Agarwal and Pitchumoni for Acute Pancreatitis |
| | | Measurement of Serum Lipase and Interleukin-6 in the Diagnosis of Acute Pancreatitis |
| | | Prediction of Mortality in Acute Pancreatitis Using Serum Creatinine and Chest Radiographs |
| | | Scoring System of Blamey et al for Separating Gallstone from Alcoholic Pancreatitis |
| | | Identification of Patients with Severe Acute Pancreatitis Using the Prognostic Factors of Fan et al |
| | | Prognostic Markers of Leese et al for Predicting Severe Disease in a Patient with Pancreatitis |
| | | Algorithm of Wilson et al Using C-Reactive Protein (CRP) to Identify a Patient at Risk for Complicated Acute Pancreatitis |
| | | Hyperlipidemic Pancreatitis |
| | | Determining a Patient's Serum Amylase Value in Hyperlipidemic Pancreatitis |
| | | Algorithm of Goodman et al for Identifying Gallstones as the Cause of Acute Pancreatitis |
| | | Biochemical Model of Sadowski et al for Identifying Gallstones as the Cause of Acute Pancreatitis |
| | | Risk Factors of Dauphine et al on Hospital Admission That Predict a Complicated Course in Acute Alcoholic Pancreatitis |
| | | Risk Factors of Arnell et al for Predicting the Need for ICU Monitoring in a Patient with Gallstone Pancreatitis |
| | | Prognostic Model of Halonen et al for Predicting Fatal Outcome in Severe Acute Pancreatitis |
| | | Level of Alcohol Abuse Associated with Development of Chronic Pancreatitis |
| | | Gallstone Features of Diehl et al Predictive for Gallstone Pancreatitis |
| | | Multiple Organ System Score (MOSS) of Taylor et al for Evaluating a Patient with Acute Pancreatitis |
| | | Urine Trypsinogen-2 and Other Markers of Lempinen et al for the Diagnosis of Severe Acute Pancreatitis |
| | | Clinical Findings in a Patient with Autoimmune Pancreatitis |
| | | Histopathologic Features of Autoimmune Pancreatitis |
| | | Criteria of Clavien et al for Identifying a Phlegmon of the Pancreas on CT Scan |
| | | Prognostic Scores of Clavien et al for Evaluating a Patient with Acute Pancreatitis |
| | | Criteria of Sarner and Cotton for Imaging Grading of Chronic Pancreatitis |
| | | Complications Associated with a Pancreatic Pseudocyst and Indications for Drainage |
| | | BALI Prognostic Model of Spitzer et al for Acute Pancreatitis |
| | | Prognostic Factors of Levy et al for a Patient with Chronic Pancreatitis |
| | | Criteria of Bradley for Severe Acute Pancreatitis (Atlanta Criteria) |
| | | Clinical Features of Tropical Chronic Pancreatitis |
| | | Criteria of McMahon et al for Severe Acute Pancreatitis Based on the Appearance of Peritoneal Fluid (Leeds Criteria) |
| | | Predictors of Poddar et al for Mortality Associated with Severe Acute Pancreatitis |
| | | Risk Factors of Seicean et al for Mortality in a Patient with Chronic Pancreatitis |
| | | Risk Factors of Makela et al for ICU Stay and Mortality in a Patient with Severe Acute Pancreatitis |
| Liver Function Test Ratios |
| |  | AST-to-ALT (SGOT-to-SGPT) Ratio |
| | | Transaminase to Glutamate Dehydrogenase Ratios |
| | | Serum Direct-to-Total Bilirubin Ratio |
| | | Half-Lives of AST and ALT Relative to Hepatocellular Injury |
| Liver Biopsy Performance and Evaluation |
| | | Identification of Ductopenia in a Liver Biopsy |
| | | Indications for Performing a Liver Biopsy |
| | | Contraindications for Performing a Liver Biopsy |
| | | The Histological Semiquantitative Scoring System (SSS) of Chevallier et al for Evaluation of Hepatic Fibrosis in Needle Liver Biopsy Specimens |
| | | Interpretation of a Frozen Section from the Donor Liver Prior to Hepatic Transplantation |
| | | Indications of McAfee et al for Performing a Transjugular Liver Biopsy |
| Cirrhosis and Portal Hypertension |
| | | The Child-Pugh Score for Grading Hepatic Cirrhosis |
| | | Prognostic Index for Nonbleeding Cirrhosis |
| | | Erasme Prognostic Score for Hepatic Cirrhosis |
| | | Predicting One Year Survival in Patients with Nonbiliary Hepatic Parenchymal Cirrhosis |
| | | Prognostic Index of Gatta et al for Patients with Liver Cirrhosis after Upper Gastrointestinal Bleeding |
| | | Multivariate Biochemical Discriminate Function of Fortunato et al for Distinguishing Cirrhosis from Chronic Hepatitis |
| | | Use of the PGA Index and Procollagen III Peptide (PIIIP) to Evaluate a Patient for Hepatic Fibrosis |
| | | Discriminant Score of Ekindjian et al to Predict Prognosis in a Patient with Alcoholic Cirrhosis |
| | | Prognostic Score of Casaril et al for Patients with Liver Cirrhosis |
| | | Prognostic Index of Schlichting et al for Patients with Cirrhosis |
| | | Model for End-Stage Liver Disease (MELD) |
| | | Prognostic Index of Christensen et al for Patients with Cirrhosis After the First Episode of Gastrointestinal Bleeding or Coma |
| | | Prognostic Index of Bustamante et al for Cirrhotic Patients with Hepatic Encephalopathy |
| | | Hepatic Venous Pressure Gradient (HVPG) and Portal Hypertension |
| | | Nonesophageal Variceal Bleeding Sites in Portal Hypertension |
| | | Congestion Index (CI) of Moriyasu et al for the Portal Vein |
| | | Modified Child-Turcotte Criteria of Campbell et al for a Patient with Cirrhosis and a Portocaval Shunt |
| | | Laboratory Markers of Oberti et al for Diagnosis of Cirrhosis in a Patient with Chronic Liver Disease |
| | | MELD-XI Score for Evaluating a Cirrhotic Patient Being Treated with Oral Anticoagulants |
| Perioperative Assessment of Patients with Hepatobiliary Disease |
| | | Predicting Postoperative Mortality in Patients with Chronic Liver Failure Undergoing Nonhepatic Surgery |
| | | Risk Factors for Perioperative Mortality in Patients Undergoing Extended Hepatic Resection |
| | | Risk Factors of del Olmo et al for Post-Operative Complications in a Patient with Cirrhosis Undergoing Nonhepatic Surgery |
| | | Contraindications of Friedman for Elective Surgery in Patients with Liver Disease |
| | | Risk Factors of Friedman Associated with Post-Operative Mortality in a Patient with Obstructive Jaundice |
| | | Risk Factors of Friedman for Perioperative Complications in Patients with Cirrhosis Undergoing Surgery |
| | | Risk Factors of Ziser et al Associated with Perioperative Morbidity and Long Term Mortality in a Patient with Cirrhosis Undergoing Surgery |
| | | Risk Factors of Dixon et al for Morbidity and Mortality After Surgery for Obstructive Jaundice |
| | | Discriminative Function of Garrison et al for Predicting Survival of a Cirrhotic Patient After Celiotomy Using Preoperative Factors |
| | | Discriminative Function of Garrison et al for Predicting Survival of a Cirrhotic Patient After Celiotomy Using Operative and Postoperative Factors |
| | | Risk Factors of Doberneck et al for Postoperative Mortality in a Patient with Nonbleeding Cirrhosis |
| | | Protocol of Sirinek et al for Improving Survival in a Patient with Cirrhosis Who is Undergoing a Major Abdominal Operation |
| | | Remnant Liver Volume to Total Liver Volume (RLV to TLV) Ratio in a Patient Undergoing Partial Hepatectomy |
| | | Remnant Liver Volume to Body Weight (RLV to BW) Ratio in a Patient Undergoing Partial Hepatectomy |
| | | Prognostic Factors of Winter et al for Evaluating a Patient Undergoing a Pancreaticoduodenectomy |
| | | Protocol of Winter et al for Monitoring Transaminases in a Patient Following Pancreatic Surgery |
| | | Model of Teh et al for Predicting 90 Day Mortality Following Surgery in a Patient with Cirrhosis |
| Hemochromatosis |
| | | Screening Tests for Hemochromatosis |
| | | Liver Biopsy Iron Concentration in Hemochromatosis |
| | | Nutritional and Dietary Recommendations for a Patient with Hemochromatosis |
| | | Criteria of the Hemochromatosis Management Working Group for Starting Phlebotomy in a Patient with Hemochromatosis |
| | | Criteria of the Hemochromatosis Management Working Group to Identify Iron Depletion and Reduce Phlebotomy Frequency in a Patient with Hemochromatosis |
| | | Using the Liver to Muscle (L/M) Signal Intensity Ratio on MRI to Estimate Hepatic Iron Stores |
| Alcoholic Liver Disease |
| | | The Initial Combined Clinical and Laboratory Index for Alcoholic Liver Disease (CCLI) of Orrego et al |
| | | The Revised Combined Clinical and Laboratory Index for Alcoholic Liver Disease (CCLI) of Orrego et al |
| | | Step-wise Discriminant Function for Alcoholic Liver Disease |
| | | Logistic Regression Function for Alcoholic Liver Disease |
| | | Discriminant Function for Methylprednisone Therapy in Severe Alcoholic Hepatitis |
| | | Recognition of Acetaminophen Hepatotoxicity in Chronic Alcoholics |
| | | PGA Index of Poynard et al for Identifying Alcoholic Liver Disease |
| | | Risk Factors for Development of Alcoholic Hepatitis |
| | | PGAA Index of Naveau et al for Evaluating a Patient with Alcoholic Liver Disease |
| | | ANI (Alcoholic Liver Disease to Nonalcoholic Fatty Liver Disease Index) Model of Dunn et al for Evaluating a Patient with Steatohepatitis |
| | | Intrahepatic Cholestasis Associated with Alcoholic Liver Disease (Pseudo Large Duct Obstruction) |
| Fulminant Hepatic Failure |
| | | King's College Hospital Criteria for Predicting Outcome of Fulminant Hepatic Failure |
| | | Probability of Fatal Outcome in Fulminant Hepatic Failure due to Acetaminophen |
| | | Modified King's College Hospital (KCH) Criteria for Liver Transplantation in Paracetamol/Acetaminophen-Induced Acute Liver Failure |
| | | Indications of Miyake et al for Liver Transplantation in a Patient with Fulminant Autoimmune Hepatitis |
| | | Discriminant Function of Christensen et al for a Patient with Fulminant Hepatitis |
| | | Prognostic Factors of Bernuau et al in Patients with Fulminant Hepatitis B |
| | | Diagnosis of Fulminant Hepatic Failure in Wilson's Disease |
| | | Criteria of Harrison et al for Paracetamol-Induced Fulminant Hepatic Failure Based on Serial Monitoring of the Prothrombin Time |
| Autoimmune Hepatitis |
| | | Scoring System for Autoimmune Hepatitis |
| | | Types of Autoimmune Hepatitis |
| Disorders of the Gallbladder and Bile Ducts |
| | | Contraindications for Laparoscopic Cholecystectomy |
| | | Identifying Patients at Low Risk for Common Bile Duct Lithiasis |
| | | Criteria for Patient Selection for Extracorporeal Biliary Lithotripsy |
| | | Predictive Factors of Alponat et al for Conversion of Laparoscopic Cholecystectomy |
| | | Scoring System of Eubanks et al for Laparoscopic Cholecystectomy |
| | | Risk Factors for Gallstone Formation |
| | | Algorithm for the Management of Postcholecystectomy Pain |
| | | Risk Factors of Pitt et al in Biliary Tract Surgery |
| | | Predictive Factors of Fried et al for Conversion of Laparoscopic Cholecystectomy |
| | | Risk Factors of Fraquelli et al for Gallstone Disease in Patients with Crohn's Disease |
| | | Mirizzi Syndrome |
| | | Cholecystenteric Fistula with Passage of Gallstones into the Intestines (Gallstone Ileus, Bouveret's Syndrome) |
| | | Rome II Criteria for Gallbladder Dysfunction |
| | | Model of Onken et al for Predicting the Probability of Choledocholithiasis in a Patient with Cholelithiasis |
| | | Histologic Grades of Kwon et al for Xanthogranulomatous Cholecystitis |
| | | Risk Factors for Bile Duct Injury During Laparoscopic Cholecystectomy |
| | | Classification of Strasberg et al for Causes of Laparoscopic Biliary Injuries |
| | | Classification of Bismuth et al for Biliary Duct Stricture After Cholecystectomy |
| | | Classification of Strasberg et al for Laparoscopic Injuries to the Biliary Tree |
| | | Criteria for Outcome Following Therapy for Biliary Obstruction |
| | | Risk Factors for Poor Outcome or Stricture Recurrence After Surgical Reconstruction of the Bile Ducts |
| | | Risk Factors of Schweizer et al Identifying a Patient with Complex Benign Biliary Tract Obstruction Who Requires Specialized Biliary Reconstruction |
| | | Differential Diagnosis of a Bile Duct Stricture |
| | | Clinical Features of Spontaneous Perforation of the Extrahepatic Bile Duct in an Infant |
| | | Clinical Features of Spontaneous Perforation of the Extrahepatic Bile Duct in an Adult |
| | | Risk Factors for Acute Acalculous Cholecystitis in a Patient in the Intensive Care Unit (ICU) |
| | | Sonographic Findings for Acute Acalculous Cholecystitis in a Patient in the Intensive Care Unit (ICU) |
| | | Clinical Findings Associated with Acute Acalculous Cholecystitis in a Patient in the Intensive Care Unit (ICU) |
| | | Evaluating Polypoid Lesions of the Gallbladder on Ultrasound |
| | | Pocket Chart of MULGO Group for Predicting Dyspeptic Symptoms 1 Year After Cholecystectomy |
| | | Pocket Chart of MULGO Group for Predicting Pain 1 Year After Cholecystectomy |
| | | Risk Factors of Mastoraki et al for Biliary Complications Following Cardiovascular Surgery |
| | | Evaluation of a Patient with Air or Gas in the Gallbladder or Common Bile Duct (Pneumobilia) |
| | | Hemobilia |
| | | Predictors of Carney et al for Benefit After Cholecystectomy for Biliary Dyskinesia in a Child |
| | | Predictors of Pang and Chun for Emergency Biliary Decompression in a Patient with Acute Cholangitis |
| | | Risk Factors for Cholelithiasis in a Patient with Acromegaly |
| | | Score of Sosna et al for Rating Ultrasound Findings of the Gallbladder |
| | | Score of Huguier et al for Predicting the Probability of Common Duct Stones |
| | | Classification of Stewart and Way for Laparoscopic Bile Duct Injury (BDI) |
| | | Scoring System of Misawa et al for Severity of Inflammation in Calot's Triangle in a Patient with Cholecystitis |
| | | Score of Sarli et al for the Risk of a Common Bile Duct Stone |
| | | Difficulty Score of Cho et al for Performing a Laparoscopic Cholecystectomy |
| | | Sonographic Factors of Cho et al for Predicting Technical Difficulties Prior to Performing a Laparoscopic Cholecystectomy |
| | | Models of Neoptolemos et al for Predicting the Risk of Complications Following Therapy for Common Bile Duct Stones |
| | | Grading Scheme of Nishimura et al for Choledochitis Based on the Endoscopic Appearance |
| | | Algorithm of Stringer et al for Management of a Pediatric Patient with a Gallbladder Polyp |
| | | Risk of Gallstones in Men Associated with Weight Cycling |
| | | Features of AIDS Cholangiopathy (AIDS-Related Sclerosing Cholangitis) |
| Evaluation of the Patient for Liver Transplantation |
| | | Contraindications to Liver Transplantation |
| | | Indications for Liver Transplantation |
| | | Score of Malatack et al for Predicting Mortality Risk in Children with End-Stage Liver Disease |
| | | United Network for Organ Sharing (UNOS) Liver Status for Adults 18 Years of Age or Older |
| | | Risk Model of Ghobrial et al for Predicting Posttransplant Survival for Liver Transplant Patients in the UNOS Database |
| | | Risk Model of Ghobrial for Predicting Posttransplant Survival in Patients with Hepatitis C Virus (HCV) Infection |
| | | Pediatric End-Stage Liver Disease (PELD) Model |
| | | Model of Ioannou for Predicting Graft Survival in a Liver Transplant Recipient with HCV |
| | | Model of Ioannou for Predicting Graft Survival in a Liver Transplant Recipient with a Liver Disease Other Than HCV |
| | | Score for Liver Donor (SOLD) of Ioannou |
| | | Predictive Factors of Farmer et al for Outcomes After Pediatric Liver Transplantation |
| Patient Evaluation Following Liver Transplantation |
| | | Early Recognition of Primary Liver Transplant Nonfunction |
| | | Identification of Reversible Severe Damage from Irreversible Initial Nonfunction of the Liver Transplant |
| | | Identification of Primary Nonfunction vs Initial Poor Function of Liver Transplant |
| | | Grading Acute Liver Allograft Rejection Using the Banff Schema |
| | | Risk Factors of Qian et al for Biliary Complications After Liver Transplantation |
| | | Operative Risk Factors of Markmann et al for Poor Outcome After Liver Transplantation |
| | | Models of Moore et al for Predicting Graft Failure and Patient Death After Liver Transplantation |
| | | Models of Burroughs et al for Predicting Mortality 3 and 12 Months After a First Liver Transplant for a European Adult |
| | | Models of Demetris et al for an Unfavorable Outcome Following Liver Transplant Based on Histologic Features |
| | | NIDDK-LTD Nomenclature and Grading Criteria for Rejection in a Biopsy from a Liver Allograft |
| Primary Biliary Cirrhosis (PBC) |
| | | Mayo Risk Score in Primary Biliary Cirrhosis |
| | | European Prognostic Index in Primary Biliary Cirrhosis |
| | | Yale Prognostic Score in Primary Biliary Cirrhosis |
| | | Relative Risk of Mortality in Primary Biliary Cirrhosis According to Rydning et al |
| | | Histologic Stages of Primary Biliary Cirrhosis |
| Primary Sclerosing Cholangitis (PSC) |
| | | Mayo Risk Score in Primary Sclerosing Cholangitis |
| | | Revised Mayo Risk Score for Primary Sclerosing Cholangitis |
| | | Prognostic Index of Broome et al for Primary Sclerosing Cholangitis in a Swedish Population |
| | | King's College-Cambridge Prognostic Index for Patients with Primary Sclerosing Cholangitis |
| | | Multicenter Risk Score for Predicting Survival in Patients with Primary Sclerosing Cholangitis |
| | | Criteria for Clinical Worsening in Patients with Primary Sclerosing Cholangitis |
| | | Primary Sclerosing Cholangitis (PSC) Score of Tischendorf et al |
| | | Histologic Stages of Ludwig and Batts in a Liver Biopsy from a Patient with Primary Sclerosing Cholangitis |
| Drug-Induced Liver Disease |
| | | Drug-Induced Liver Injury Diagnostic Scale |
| Reye's Syndrome |
| | | Clinical Staging of Reye's Syndrome |
| | | Criteria for Excluding or Considering Reye's Syndrome Unlikely |
| | | Centers for Disease Control and Prevention Definition of Reye's Syndrome |
| | | Criteria for the Certain or Probable Diagnosis of Reye's Syndrome |
| In Vivo Measurement of Organ Volume |
| | | Method of Zoli et al for In Vivo Measurement of Liver Volume by Ultrasound Using 3 Diameters |
| | | Sonographic Biometry of Liver Size in Childhood |
| | | Equation of of Dodds et al for Sonographic Measurement of Gallbladder Volume |
| Methotrexate Hepatotoxicity |
| | | Classification of Roenigk et al for Liver Biopsy Findings in Patients Receiving Methotrexate Therapy |
| | | Risk Factors of West for Methotrexate Hepatotoxicity |
| | | American College of Rheumatology Recommendations for Monitoring Patients with Rheumatoid Arthritis Taking Methotrexate |
| Nonalcoholic Steatohepatitis (NASH) |
| | | Grading and Staging Scheme for Nonalcoholic Steatohepatitis of Brunt et al |
| | | Risk Factors for Nonalcoholic Steatohepatitis |
| | | Predictors of Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis |
| | | Modified Criteria of Lee for Histologic Scoring of Nonalcoholic Steatohepatitis |
| | | Histologic Scoring and Grading System of Mendler et al for Non-Alcoholic Fatty Liver Disease (NAFLD) |
| | | Fatty Liver Index (FLI) of Bedogni et al for Predicting Hepatic Steatosis |
| | | Model of Tanaka et al for Distinguishing Patients with Nonalcoholic Steatohepatitis (NASH) from Those with Cryptogenic Chronic Hepatitis |
| | | Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score (NAS) of Kleiner et al |
| Gallbladder Ejection Fraction |
| | | Gallbladder Ejection Fraction |
| Wilson's Disease |
| | | Patients Who Should be Screened for Wilson's Disease |
| | | Copper Levels in a Liver Biopsy |
| | | Interpretation of a Serum Ceruloplasmin Concentration |
| | | Neuropsychiatric Features of Wilson's Disease |
| | | Prognostic Factors of Prashanth et al for a Patient with a Severe Neurologic Form of Wilson's Disease |
| | | Dietary Recommendations for a Patient with Wilson's Disease |
| | | Indications for Liver Transplantation in a Patient with Wilson's Disease |
| | | Hepatobiliary Presentations in a Patient with Wilson's Disease |
| | | Oral Zinc Therapy in a Patient with Wilson's Disease |
| | | Penicillamine Challenge Test for Urinary Copper Excretion |
| Congenital Malformations of the Biliary System |
| | | Classification of Todani et al for Congenital Bile Duct Cysts (Choledochal Cysts) |
| Inherited Disorders of Bilirubin Excretion |
| | | Diagnostic Approach of Pinos et al for the Dubin-Johnson Syndrome |
| | | Diagnostic Features of Gilbert's Syndrome |
| Air or Gas in the Liver or Portal Vein |
| | | Air or Gas in the Liver or Portal Vein |
| Sphincter of Oddi |
| | | Criteria of Geenen et al for Sphincter of Oddi Dysfunction |
| | | Rome II Conference Criteria for Sphincter of Oddi Dysfunction |
| Endoscopic Retrograde Cholangiopancreatography (ERCP) |
| | | Indications for Endoscopic Retrograde Cholangiopancreatography (ERCP) |
| | | Risk Factors of Vandervoort for Complications After Performing ERCP |
| | | Risk Factors of Cheng et al for Pancreatitis After ERCP |
| | | Risk Factors of Mehta et al for Pancreatitis After ERCP Performed on a Patient with Suspected Choledocholithiasis |
| | | Criteria and Riak Factors of Christoforidis et al for Post-ERCP Pancreatitis and Hyperamylasemia |
| Chronic Hepatitis |
| | | Grading and Staging Chronic Hepatitis in a Liver Biopsy |
| | | Algorithm of Bedossa and Poynard (METAVIR CSG) for Grading the Activity of Chronic Hepatitis C in a Liver Biopsy |
| | | Score of Forns et al for Excluding Significant Hepatic Fibrosis in Patients with Chronic Hepatitis C |
| | | Discriminant Score of Bonacini et al for Predicting Cirrhosis in a Patient with Chronic Viral Hepatitis C |
| | | Comprehensive Clinical Assessment of Gordon et al for Predicting Cirrhosis in a Patient with Chronic Viral Hepatitis C |
| | | Discriminant Score of Teran et al for the Diagnosis of Cirrhosis in a Patient with Chronic Hepatitis |
| | | Hepascore of Adams et al for Predicting Hepatic Fibrosis in a Patient with Chronic Viral Hepatitis C |
| | | Clinical Risk Factors of Romagnuolo et al for Predicting Histologic Findings in a Liver Biopsy from a Patient with Chronic Viral Hepatitis C (HCV) |
| | | AST to Platelet Ratio Index (APRI) and Other Models of Wai et al for Predicting Significant Fibrosis and Cirrhosis in a Patient with Chronic Viral Hepatitis C (HCV) |
| | | Model of Kaul et al for Predicting Cirrhosis in a Patient with Chronic Viral Hepatitis C (HCV) |
| | | Spleen-Platelet Ratio Index (SPRI) and Age-Spleen-Platelet Ratio Index (ASPRI) to Predict Hepatic Cirrhosis in a Patient with Chronic Viral Hepatitis B |
| Veno-Occlusive Disease (VOD, Sinusoidal Obstructive Syndrome) |
| | | Classification of Kumar et al for Veno-Occlusive Disease Severity |
| | | Criteria of McDonald et al for the Diagnosis of Veno-Occlusive Disease (Seattle Criteria) |
| | | Criteria of Jones et al for the Diagnosis of Veno-Occlusive Disease (Baltimore or Hopkins Criteria) |
| | | Modified Criteria of McDonald et al for the Diagnosis of Veno-Occlusive Disease (Modified Seattle Criteria) |
| | | Histologic Patterns of Veno-Occlusive Disease (VOD) |
| | | Risk Factors for Veno-Occlusive Disease (VOD) in a Liver Transplant Patient |
| | | Veno-Occlusive Disease Due to Pyrrolizidine Alkaloids in Herbal and Bush Teas |
| Budd-Chiari Syndrome |
| | | Grading System of Tanaka and Wanless for Vascular Lesions in Patients with Budd-Chiari Syndrome |
| | | Prognostic Index of Zeitoun et al for a Patient with the Budd-Chiari Syndrome |
| Evaluation of the Patient with Jaundice or Hyperbilirubinemia |
| | | Initial Testing to Determine the Cause of Hyperbilirubinemia |
| Pancreatic Complications After Surgery |
| | | Criteria for Pancreatic Fistula |
| | | Risk Factors of Tien et al for Massive Hemorrhage in a Patient with a Pancreatic Leak After a Pancreaticoduodenectomy |
| Pancreas Transplantation |
| | | Eligibility Criteria for Pancreas Transplantation |
| | | Absolute and Relative Contraindications for Pancreas Transplantation |
| | | Criteria of Drachenberg et al for Grading Acute Rejection of a Pancreatic Transplant |
| Portal Vein Thrombosis |
| | | Risk Factors for Portal Vein Thrombosis |
| | | Clinical Findings in a Patient with Portal Vein Thrombosis |
| Hepatic Hemangiomas |
| | | Clinical Features of an Hepatic Hemangioma |
| | | Features of Shimizu et al Suggesting the Presence of an Hepatic Hemangioma in a Patient with a Suspected Liver Metastasis |
| Hypoxic Liver Injury (Hypoxic Hepatitis) |
| | | Clinical Criteria for Hypoxic Liver Injury |
| | | Risk Factors for Hypoxic Liver Injury |
| Sickle Cell Hepatopathy |
| | | Clinical Features of Acute Sickle Hepatic Crisis |
| | | Clinical Features of Acute Hepatic Sequestration Crisis in Sickle Cell Anemia |
| | | Reverse Sequestration in Sickle Cell Anemia |
| | | Clinical Features of Acute Sickle Cell Intrahepatic Cholestasis |
| Premalignant Lesions of the Pancreas |
| | | Histologic Features of Pancreatic Intraepithelial Neoplasia (PanIN) |
| |
| TOP |